Ast Spacemobile's Rapid Growth Highlights Iridium's Stagnant Revenue Amid High Leverage and Contract Risks

What happened

Ast Spacemobile has transitioned from minimal sales to steep quarter-over-quarter revenue growth over the last eight quarters, significantly narrowing the gap with Iridium Communications, which has maintained a relatively flat, stable revenue base. This contrast underscores Iridium's current reality of slowing ~3% service-revenue growth, as detailed in the DeepValue report, driven by broadband ARPU compression and declining U.S. government voice subscribers. Iridium's stability stems from its mature LEO constellation and fixed-cost network, but it masks elevated net leverage at 4.1x EBITDA and binary risks with the EMSS contract renewal in 2026-27, which could materially impact revenue. The report rates Iridium as 'WAIT' with a conviction of 2.5, citing limited upside until EMSS clarity or acceleration from new platforms like STL and NTN Direct. Ast's growth trajectory reinforces the competitive pressures in the satellite sector, where Iridium must execute on strategic initiatives to offset these headwinds and justify its valuation.

Implication

The comparison with Ast Spacemobile highlights that Iridium's revenue stability is a double-edged sword, reflecting both operational maturity and growth stagnation in a dynamic competitive landscape. For investors, this reinforces the DeepValue report's 'WAIT' rating, suggesting patience until Iridium demonstrates clearer progress on contract renewals or growth acceleration from initiatives like STL and NTN Direct. Given Iridium's net leverage of 4.1x and concentrated government exposure, any misstep in EMSS negotiations or delayed new revenue streams could exacerbate balance-sheet stress and limit equity upside. While the stock trades at a modest 9.1x EV/EBITDA, the implied base case value of $22 offers only mid-teens returns, insufficient against the backdrop of binary risks and emerging competition. Therefore, monitoring quarterly service-revenue trends, leverage metrics, and EMSS updates over the next 6-12 months is critical, with an attractive entry point remaining near $17 for improved risk-reward.

Thesis delta

The article does not shift the core investment thesis but reinforces it by highlighting competitive dynamics that align with existing concerns. Iridium's flat revenue growth compared to Ast's rapid expansion underscores the urgency for successful execution on EMSS renewal and new platforms like STL and NTN Direct to reaccelerate growth. The thesis remains unchanged: wait for a cheaper entry or clearer acceleration before committing capital, given the high leverage and contract risks.